Aidence
Aidence is a radiology AI company founded in Amsterdam in 2015 that builds clinical AI for the lung cancer pathway. Its flagship product, Veye Lung Nodules (now DeepHealth Lung), is a CE-marked AI solution that detects, classifies, quantifies, and measures growth of pulmonary nodules on chest CT scans, and is the AI of choice in NHS England's Targeted Lung Health Checks screening programme. Aidence was acquired by RadNet in 2022 and now operates under the DeepHealth brand; aidence.com redirects to deephealth.com/aidence. The product integrates with hospital systems over DICOM/PACS via the Veye Engine rather than a public developer REST API — no public API, developer portal, or SDKs are published. This profile captures the company's identity plus its probed security and disclosure posture.
Aidence is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Artificial Intelligence, Radiology, and Medical Imaging.
Aidence’s developer surface includes support, engineering blog, and 11 more developer resources.
Kin Score
Security Posture 3
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 6
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API